Featured Research

from universities, journals, and other organizations

There's no place like home -- For dialysis

Date:
October 4, 2012
Source:
American Society of Nephrology
Summary:
Home hemodialysis could allow patients to enjoy increased freedom, quality of life, greater ability to travel, and tangible health improvements. Increased physician and patient education can eliminate barriers to home hemodialysis and increase its use. Approximately 2 million patients in the world receive some sort of dialysis treatment.

Most patients with chronic kidney disease who undergo hemodialysis put up with a grueling treatment regimen that involves going into a clinic several days a week and sitting through a three-to-four hour dialysis session at each visit. Home hemodialysis is more accessible than ever, though, with the advent of newer systems that are easier for patients to learn, use, and maintain, according to a review appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

The authors offer suggestions for how to overcome barriers and establish a successful home hemodialysis program.

"There is virtually no other disease that requires patients to make such considerable changes in their lifestyle as a diagnosis of end-stage renal disease and the need for dialysis therapy does," said Rajnish Mehrotra, MD (University of Washington, Seattle). "To ease the challenge associated with such a diagnosis, offering patients choice allows them to select a dialysis therapy that best fits into their lifestyle and their expectations."

Home hemodialysis is one type of dialysis therapy, but it is available to less than 2% of dialysis patients in the country. Home hemodialysis requires extensive patient training, nursing education, and infrastructure support to maintain a successful program. Also, reluctance to start such programs is widespread because many physicians do not have experience with home hemodialysis.

Bessie Young, MD (University of Washington, Seattle) worked with Dr. Mehrotra and others to provide an in-depth review to describe the benefits and barriers to home hemodialysis, focusing on patients, physicians, practices, and dialysis facilities.

Benefits of home hemodialysis include:

• Potential for greater dialysis delivery (more frequent or overnight treatments)

• Improved quality of life

• Patient independence and employment potential

• Greater ability to travel

• 20%-50% less costly than in-center hemodialysis depending on the machine.

Barriers to home hemodialysis include:

• Lack of patient awareness and education about home hemodialysis

• Patients' perceptions, including fear of change and lack of self-confidence

• Physicians' education about home hemodialysis

• Machine complexity, which is now minimal with newer, easier-to-use systems

• Inadequate payment to providers for home hemodialysis training.

"Home hemodialysis has been successfully used by thousands of patients and should be available to everyone on or initiating dialysis. It is a safe, efficient modality that allows patients the ability to increase their frequency of dialysis, which may provide a potential survival benefit," said Dr. Young.

Study co-authors include Christopher Chan, MD, Christopher Blagg, MD, Robert Lockridge, MD, Thomas Golper, MD, Fred Finkelstein, MD, Rachel Shaffer, and Rajnish Mehrotra on behalf of the ASN Dialysis Advisory Group (DAG).


Story Source:

The above story is based on materials provided by American Society of Nephrology. Note: Materials may be edited for content and length.


Journal Reference:

  1. B. A. Young, C. Chan, C. Blagg, R. Lockridge, T. Golper, F. Finkelstein, R. Shaffer, R. Mehrotra. How to Overcome Barriers and Establish a Successful Home HD Program. Clinical Journal of the American Society of Nephrology, 2012; DOI: 10.2215/CJN.07080712

Cite This Page:

American Society of Nephrology. "There's no place like home -- For dialysis." ScienceDaily. ScienceDaily, 4 October 2012. <www.sciencedaily.com/releases/2012/10/121004201044.htm>.
American Society of Nephrology. (2012, October 4). There's no place like home -- For dialysis. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/10/121004201044.htm
American Society of Nephrology. "There's no place like home -- For dialysis." ScienceDaily. www.sciencedaily.com/releases/2012/10/121004201044.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins